Adjuvia Therapeutics, a biotechnology company developing novel therapeutics to treat mitochondrial dysfunction and disease, ...
Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Friedreich's Ataxia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
Obtaining Orphan designation from the European Commission reflects Solid’s commitment to the global development of SGT-212 for individuals living with Friedreich’s ataxia - - SGT-212 is a ...
Friedreich’s ataxia is a progressive neuromuscular disease that causes uncoordinated movement, muscle weakness, balance problems, impaired speech, and frequently, heart abnormalities. Most treatments ...
The dynamics of the Friedreich's ataxia market are anticipated to change as companies across the globe are thoroughly working toward the development of new drug therapy options to treat this disease.
Michelle Beagan is now fighting for access to a drug that could slow Friedreich's ataxia, a rare progressive genetic neurodegenerative movement condition.
Friedreich’s ataxia is a genetic condition that affects the nervous system. It’s caused by a change in a gene responsible for regulating energy production within cells. This change means that the ...
Friedreich ataxia patients struggle with timely diagnosis and access to specialized care due to the disease's rarity and complexity. Families and caregivers experience significant emotional and ...
Friedreich’s ataxia is a chronic, progressive neurological condition that leads to impaired muscle coordination. This can affect balance and mobility as well as speech and heart health. Friedreich’s ...
Cardiac complications like arrhythmias, heart failure, and myocardial infarction significantly impact mortality rates in patients with comorbidities. The interaction between cardiac issues and ...
Solid Biosciences Inc. ( SLDB) announced that the European Commission has granted Orphan Medicinal Product designation to SGT-212, an investigational gene therapy being developed to treat Friedreich's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results